These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 20379108

  • 1. [Intravascular large B-cell lymphoma with pontine involvement successfully treated with R-hyper-CVAD/R-MTX-Ara-C regimen].
    Nakazato T, Suzuki K, Mihara A, Sanada Y, Yoshida S, Kakimoto T.
    Rinsho Ketsueki; 2010 Feb; 51(2):148-52. PubMed ID: 20379108
    [Abstract] [Full Text] [Related]

  • 2. [Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
    Suzuki K, Nakazato T, Sanada Y, Mihara A, Tachikawa N, Kurai H, Yoshimura Y, Hayashi H, Yoshida S, Kakimoto T.
    Rinsho Ketsueki; 2010 Mar; 51(3):207-12. PubMed ID: 20379116
    [Abstract] [Full Text] [Related]

  • 3. [Case of peritubular capillary dominant intravascular large B-cell lymphoma (PTC dominant IVLBCL) successfully treated with chemotherapy].
    Kado H, Hatta T, Ueno R, Takagi A, Segawa H, Sawada K, Hosokawa Y.
    Nihon Jinzo Gakkai Shi; 2011 Mar; 53(7):1046-52. PubMed ID: 22073871
    [Abstract] [Full Text] [Related]

  • 4. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA, O'Brien S, Thomas DA, Pierce SA, Lam TP, Kantarjian HM.
    Cancer; 2002 Jan 15; 94(2):285-91. PubMed ID: 11900213
    [Abstract] [Full Text] [Related]

  • 5. The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma.
    Ritchie DS, Seymour JF, Grigg AP, Roberts AW, Hoyt R, Thompson S, Szer J, Prince HM.
    Ann Hematol; 2007 Feb 15; 86(2):101-5. PubMed ID: 17089127
    [Abstract] [Full Text] [Related]

  • 6. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA, Cabanillas ME, Konopleva M, Thomas DA, Pierce SA, Escalante CP, Kantarjian HM, O'Brien SM.
    Cancer; 2004 Mar 15; 100(6):1179-85. PubMed ID: 15022284
    [Abstract] [Full Text] [Related]

  • 7. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
    Takeoka Y, Inaba A, Fujitani Y, Kosaka S, Yamamura R, Senzaki H, Okamura T, Ohta K.
    Rinsho Ketsueki; 2011 Nov 15; 52(11):1777-81. PubMed ID: 22185801
    [Abstract] [Full Text] [Related]

  • 8. [A case of pulmonary intravascular lymphoma treated with CHOP chemotherapy plus rituximab].
    Ohkubo H, Yoshida T, Ohta K, Takaku T, Katagiri T, Paku J, Kasuga I, Minemura K, Gotoh A, Serizawa H, Mukai K, Ohyashiki K.
    Gan To Kagaku Ryoho; 2005 Apr 15; 32(4):553-6. PubMed ID: 15853227
    [Abstract] [Full Text] [Related]

  • 9. [Dramatic but temporary improvements in a case of CNS intravascular malignant lymphomatosis].
    Aoyama M, Aoki T, Matsuura Y, Yamanoi T, Watanabe A, Saitou N, Honma M, Ishikawa T, Kodama N, Yamamoto T.
    Rinsho Shinkeigaku; 2003 Apr 15; 43(1-2):6-11. PubMed ID: 12820543
    [Abstract] [Full Text] [Related]

  • 10. [Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma].
    Shimada K.
    Brain Nerve; 2011 May 15; 63(5):467-72. PubMed ID: 21515926
    [Abstract] [Full Text] [Related]

  • 11. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
    Shapiro M, Wasik MA, Junkins-Hopkins JM, Rook AH, Vittorio CC, Itakura H, Frankel MC, Georgala S, Schuster SJ.
    Am J Hematol; 2003 Sep 15; 74(1):46-51. PubMed ID: 12949889
    [Abstract] [Full Text] [Related]

  • 12. [Definitive diagnosis of intravascular large B-cell lymphoma by random skin biopsy].
    Kotake T, Takamori H, Kuwayama M, Hattori H, Takeda M, Takagi K, Karasuno T.
    Gan To Kagaku Ryoho; 2011 Aug 15; 38(8):1361-4. PubMed ID: 21829082
    [Abstract] [Full Text] [Related]

  • 13. Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
    Inamdar KV, Romaguera JE, Drakos E, Knoblock RJ, Garcia M, Leventaki V, Medeiros LJ, Rassidakis GZ.
    Cancer; 2009 Oct 15; 115(20):4727-36. PubMed ID: 19708031
    [Abstract] [Full Text] [Related]

  • 14. [Intravascular large B-cell lymphoma: an important cause of fever of unknown origin].
    Masaki Y, Miki M, Sakai T, Sawaki T, Fukushima T, Umehara H.
    Brain Nerve; 2011 May 15; 63(5):435-41. PubMed ID: 21515922
    [Abstract] [Full Text] [Related]

  • 15. [Intravascular large B-cell lymphoma with massive pulmonary lesions].
    Higashiyama A, Hashino S, Onozawa M, Takahata M, Okada K, Kahata K, Taniguchi N, Nasuhara Y, Kubota K, Fujimoto N, Matsuno Y, Nishimura M, Asaka M.
    Rinsho Ketsueki; 2010 May 15; 51(5):353-6. PubMed ID: 20534958
    [Abstract] [Full Text] [Related]

  • 16. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
    Feldmann R, Schierl M, Sittenthaler M, Jahn R, Wogritsch C, Cerroni L, Steiner A, Breier F.
    Dermatology; 2009 May 15; 219(4):344-6. PubMed ID: 19590171
    [Abstract] [Full Text] [Related]

  • 17. [Intravascular lymphoma confirmed by brain biopsy, quickly treated by chemotherapy: a case report].
    Inoue D, Hamamura T, Uehara T, Miyoshi K, Katsuragi T, Takeshita I, Hamada T.
    No Shinkei Geka; 2009 Apr 15; 37(4):369-74. PubMed ID: 19364028
    [Abstract] [Full Text] [Related]

  • 18. Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine.
    Garcia M, Romaguera JE, Inamdar KV, Rassidakis GZ, Medeiros LJ.
    Cancer; 2009 Mar 01; 115(5):1041-8. PubMed ID: 19170236
    [Abstract] [Full Text] [Related]

  • 19. High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
    Romaguera JE, Fayad L, Rodriguez MA, Broglio KR, Hagemeister FB, Pro B, McLaughlin P, Younes A, Samaniego F, Goy A, Sarris AH, Dang NH, Wang M, Beasley V, Medeiros LJ, Katz RL, Gagneja H, Samuels BI, Smith TL, Cabanillas FF.
    J Clin Oncol; 2005 Oct 01; 23(28):7013-23. PubMed ID: 16145068
    [Abstract] [Full Text] [Related]

  • 20. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.
    Thomas DA, Faderl S, O'Brien S, Bueso-Ramos C, Cortes J, Garcia-Manero G, Giles FJ, Verstovsek S, Wierda WG, Pierce SA, Shan J, Brandt M, Hagemeister FB, Keating MJ, Cabanillas F, Kantarjian H.
    Cancer; 2006 Apr 01; 106(7):1569-80. PubMed ID: 16502413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.